Janey M. Stone

914 total citations
15 papers, 721 citations indexed

About

Janey M. Stone is a scholar working on Pathology and Forensic Medicine, Oncology and Surgery. According to data from OpenAlex, Janey M. Stone has authored 15 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 7 papers in Oncology and 3 papers in Surgery. Recurrent topics in Janey M. Stone's work include Lymphoma Diagnosis and Treatment (8 papers), Viral-associated cancers and disorders (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Janey M. Stone is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Viral-associated cancers and disorders (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Janey M. Stone collaborates with scholars based in Australia, New Zealand and Switzerland. Janey M. Stone's co-authors include John C. Walker, Deborah Cruickshank, T. F. Sandeman, Jane Matthews, Max Wolf, John F. Seymour, Janine Campbell, Surender Juneja, I. A. Cooper and JP Matthews and has published in prestigious journals such as Journal of Clinical Oncology, PLANT PHYSIOLOGY and Cancer.

In The Last Decade

Janey M. Stone

15 papers receiving 688 citations

Peers

Countries citing papers authored by Janey M. Stone

Since Specialization

Citations

This map shows the geographic impact of Janey M. Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janey M. Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janey M. Stone more than expected).

Fields of papers citing papers by Janey M. Stone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janey M. Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janey M. Stone. The network helps show where Janey M. Stone may publish in the future.

Co-authorship network of co-authors of Janey M. Stone

This figure shows the co-authorship network connecting the top 25 collaborators of Janey M. Stone. A scholar is included among the top collaborators of Janey M. Stone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janey M. Stone. Janey M. Stone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03) 2018 ·International Journal of Radiation OncologyBiologyPhysics ·Andrew Wirth, H. Miles Prince, Daniel Roos, John Gibson, Peter C. O’Brien, Diana Zannino, (unknown), Janey M. Stone, Sidney Davis, Mark Hertzberg	5
2	A phase II study of a modified hyper-CVAD frontline therapy for patients with adverse risk diffuse large B-cell and peripheral T-cell non-Hodgkin lymphoma 2018 ·Leukemia & lymphoma ·Greg Hapgood, Janey M. Stone, Diana Zannino, (unknown), Paula Marlton, H. Miles Prince, (unknown), I Prosser, Ian D. Lewis, Kenneth F. Bradstock, John F. Seymour, (unknown)	8
3	A phase III randomized trial of high‐dose CEOP + filgrastim versus standard‐dose CEOP in patients with non‐Hodgkin lymphoma: 10‐year follow‐up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial 2014 ·American Journal of Hematology ·Mark Hertzberg, Jane Matthews, Janey M. Stone, Ming‐Celine Dubosq, Andrew Grigg, David W. Ellis, (unknown), Peter Browett, Noemi Horvath, Henry Januszewicz, Ehtesham Abdi, Michael R. Green, (unknown), Paula Marlton, Paul Cannell, Max Wolf, (unknown)	8
4	Risk and response adapted therapy for early stage Hodgkin lymphoma: a prospective multicenter study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group 2011 ·Leukemia & lymphoma ·Andrew Wirth, Andrew Grigg, Max Wolf, David Goldstein, Carol Johnson, Sidney Davis, Gaelle Dutu, (unknown), Carole Smith, Andrew Kneebone, Mark C. Herzberg, David Joseph, John Catalano, Daniel Roos, Janey M. Stone, John Reynolds	1
5	Phase II study of autologous stem cell transplant using busulfan–melphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphoma 2010 ·Leukemia & lymphoma ·Andrew Grigg, Janey M. Stone, Alvin Milner, Anthony P. Schwarer, Max Wolf, H. Miles Prince, John F. Seymour, Devinder Gill, David W. Ellis, John Bashford, (unknown)	2
6	The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement 2006 ·European Journal Of Haematology ·Janine Campbell, John F. Seymour, Jane Matthews, Max Wolf, Janey M. Stone, Surender Juneja	80
7	Optimal scheduling to reduce morbidity of involved field radiotherapy with transplantation for lymphomas: A Prospective Australasian Leukaemia and Lymphoma Group Study 2004 ·Bone Marrow Transplantation ·A. Wirth, H. Miles Prince, M Wolf, Janey M. Stone, JP Matthews, John Gibson, Colin Macleod, Jeff Szer, Andrew Grigg, Bik To, Daniel Roos, Anthony P. Schwarer, Susan R. Davis, (unknown)	11
8	Plant Protein Kinase Families and Signal Transduction 1995 ·PLANT PHYSIOLOGY ·Janey M. Stone, John C. Walker	379
9	Selection of patients for randomised trials: a study based on the MACOP‐B vs CHOP in NHL study 1994 ·Australian and New Zealand Journal of Medicine ·Janey M. Stone, Christine Laidlaw, F Page, I. A. Cooper	9
10	Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group. 1994 ·Journal of Clinical Oncology ·I. A. Cooper, M. Wolf, T. I. Robertson, R. M. Fox, JP Matthews, Janey M. Stone, (unknown), G Dart, Frank Firkin	83
11	Laterality, maldescent, trauma and other clinical factors in the epidemiology of testis cancer in Victoria, Australia 1991 ·British Journal of Cancer ·Janey M. Stone, Deborah Cruickshank, T. F. Sandeman, (unknown)	51
12	Trebling of the incidence of testicular cancer in victoria, australia (1950–1985) 1991 ·Cancer ·Janey M. Stone, Deborah Cruickshank, T. F. Sandeman, Jane Matthews	50
13	ACCURACY OF DEATH CERTIFICATES AND MORTALITY STATISTICS IN VICTORIAN TESTIS CANCER DEATHS 1950–1977 1990 ·Community Health Studies ·Janey M. Stone, Deborah Cruickshank, T. F. Sandeman	3
14	Testicular cancer survey 1986 ·The Medical Journal of Australia ·Janey M. Stone	17
15	Chemoimmunotherapy for maintenance in acute myeloblastic leukemia 1976 ·Cancer ·M. G. Whiteside, M.N. Cauchi, (unknown), Janey M. Stone	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact